- ►annals.org [PDF] J Al-Salman, H Arjomand, DG Kemp, M Mittal - Annals of internal medicine, 2000 - Am Coll Physicians Jameela Al-Salman, MD; Heider Arjomand, MD; David G. Kemp, MD; and Manoj Mittal,
MD ... Background: Rosiglitazone maleate (Avandia, SmithKline Beecham,
Philadelphia, Pennsylvania) is a new oral hypo- glycemic agent approved for ... Cited by 181 - Related articles - BL Direct - All 6 versions
LM Forman, DA Simmons, RH Diamond - Annals of internal medicine, 2000 - Am Coll Physicians Lisa M. Forman, MD; David A. Simmons, MD; and Robert H. Diamond, MD ...
Background: Rosiglitazone maleate is the second ap- proved oral hypoglycemic
agent of the thiazolidinedione class. The first, troglitazone, has been ... Cited by 180 - Related articles - BL Direct - All 7 versions
K Maeda - Annals of internal medicine, 2001 - ncbi.nlm.nih.gov 1: Ann Intern Med. 2001 Aug 21;135(4):306. Hepatocellular injury in a patient
receiving pioglitazone. Maeda K. Publication Types ... Cited by 69 - Related articles - BL Direct
- ►annals.org [PDF] LD May, JH Lefkowitch, MT Kram, DE Rubin - Annals of internal medicine, 2002 - Am Coll Physicians Louis D. May, MD; Jay H. Lefkowitch, MD; Michael T. Kram, MD; and David E.
Rubin, MD ... Background: Pioglitazone is an oral hypoglycemic agent in the
thiazolidinedione class. Only one case of hepatotoxicity related to this ... Cited by 86 - Related articles - All 6 versions
J Freid, D Everitt, J Boscia - Annals of Internal Medicine, 2000 - Am Coll Physicians Letters commenting on an Annals article will be considered if they are received
within 6 weeks of the time the article was published. Only some of the letters
received can be published. Published letters are edited and may be ... Cited by 45 - Related articles - BL Direct - All 2 versions
HE Gouda, A Khan, J Schwartz, RI Cohen - The American Journal of Medicine, 2001 - Elsevier An 82-year-old man was admitted with a 3-week history of malaise, nausea, and
generalized weakness. He had a history of diabetes, coronary artery disease,
cholecystectomy, and a chromophilic pituitary adenoma that was treated ... Cited by 32 - Related articles - BL Direct - All 6 versions
MP Chase, JC Yarze - The American journal of gastroenterology, 2002 - cat.inist.fr Pioglitazone-associated fulminant hepatic failure. Michael P CHASE, Joseph
C YARZE The American journal of gastroenterology 97:22 ... Cited by 32 - Related articles - BL Direct - All 6 versions
RS Ravinuthala, U Nori - Annals of internal medicine, 2000 - ncbi.nlm.nih.gov 1: Ann Intern Med. 2000 Oct 17;133(8):658. Comment on: Ann Intern Med. 2000 Jan
18;132(2):118-21. Ann Intern Med. 2000 Jan 18;132(2):121-4. ... Cited by 23 - Related articles - BL Direct - All 2 versions
HL Bonkovsky, R Azar, S Bird, G Szabo, B … - Digestive diseases and sciences, 2002 - Springer Troglitazone maleate (Rezulin) has been associated with severe hepatotoxicity,
which led to its withdrawal from the US market in March 2000. Rosiglitazone
maleate (Avandia) is being marketed as a safe alternative in the treatment ... Cited by 41 - Related articles - BL Direct - All 5 versions
BHR Wolffenbuttel, R Gomis, S Squatrito, NP … - Diabetic Medicine, 2000 - ingentaconnect.com Methods For the intention-to-treat analysis, 574 patients (59% male, mean age 61
years) were available, randomized to receive 26 weeks of twice-daily placebo (n
= 192), rosiglitazone 1 mg (n = 199) or rosiglitazone 2 mg (n = 183) in ... Cited by 247 - Related articles - BL Direct - All 5 versions
